Omnia SanaPlant Comparison
Purple coneflower vs White clover
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Purple coneflower and White clover: they share 7 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Purple coneflower | White clover | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cold & flu | 1/10 | 1/10 | Comparable evidence |
| Immune support | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 7/10 | Stronger for White clover |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
Present in small amounts; not significant in normal food or tea use.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from immunomodulator action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from antimicrobial action
Safety, Cautions & Contraindications
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
Generally very safe as a food and in moderate herbal use. Cyanogenic glucosides present in very small amounts — not significant in normal food or tea use. Isoflavones are phytoestrogens (as in red clover) — same precautions apply in hormone-sensitive conditions. Well tolerated by most people.
External Ids
Botanical Description
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Low, creeping perennial herb rooting at the nodes, with trifoliate leaves, each leaflet oval and often marked with a pale chevron. Rounded white (sometimes pink-tinged) flower heads are borne on long stalks above the foliage.[30]
Habitat
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Grows in lawns, pastures, meadows and grassy waste ground; native to Europe and western Asia and now naturalised worldwide, including as a common lawn and forage plant.[30]
Harvesting
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
Flowering heads and leaves are picked through the flowering season and dried in a warm, shaded, airy place.[30]
Traditional Uses
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
White clover has a folk tradition, similar to but lighter than its relative red clover, as an anti-inflammatory and wound-healing remedy and mild expectorant, and modern research on its isoflavones and phenolics has additionally investigated antioxidant, kidney-protective and liver-protective activity.[30, 31, 32]
Preparations
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
Dried flower and leaf infused in hot water as a traditional mild tonic and expectorant tea.
Dosage
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
- Ngangom, L., Venugopal, D. and Pandey, N (2024) 'Investigation of Trifolium repens L. from the Indian Himalayan region as a phyto-therapeutic agent', Natural Product Research, 38(24), pp. 4468-4478. doi:10.1080/14786419.2023.2299319 Meta-analysis / review
https://doi.org/10.1080/14786419.2023.2299319 - Ahmad, S. and Zeb, A (2020) 'Phytochemical profile and pharmacological properties of Trifolium repens', Journal of Basic and Clinical Physiology and Pharmacology, 32(3), pp. 20200015. doi:10.1515/jbcpp-2020-0015 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2020-0015 - Sarno, F., Pepe, G., Termolino, P., Carafa, V. and others (2020) 'Trifolium repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway', Cells, 9(2), pp. 379. doi:10.3390/cells9020379 Preclinical
https://doi.org/10.3390/cells9020379 - Ahmad, S. and Zeb, A (2020) 'Nephroprotective property of Trifolium repens leaf extract against paracetamol-induced kidney damage in mice', 3 Biotech, 10(12), pp. 541. doi:10.1007/s13205-020-02539-0 Preclinical
https://doi.org/10.1007/s13205-020-02539-0 - Kolodziejczyk-Czepas, J (2012) 'Trifolium species-derived substances and extracts--biological activity and prospects for medicinal applications', Journal of Ethnopharmacology, 143(1), pp. 14-23. doi:10.1016/j.jep.2012.06.048 Meta-analysis / review
https://doi.org/10.1016/j.jep.2012.06.048 - Chen, Y.H., Chen, P., Wang, Y., Yang, C.H., Wu, X., Wu, C.J., Luo, L., Wang, Q., Niu, C. and Yao, J.Y (2019) 'Structural characterization and anti-inflammatory activity evaluation of chemical constituents in the extract of Trifolium repens L', Journal of Food Biochemistry, 43(9), pp. e12981. doi:10.1111/jfbc.12981 Preclinical
https://doi.org/10.1111/jfbc.12981 - Habibi Zadeh, S.K., Farahpour, M.R. and Kar, H.H (2020) 'The effect of topical administration of an ointment prepared from Trifolium repens hydroethanolic extract on the acceleration of excisional cutaneous wound healing', Wounds, 32(9), pp. 253-261. doi:10.25270/wnds/2020.253261 Preclinical
https://doi.org/10.25270/wnds/2020.253261 - Kicel, A. and Wolbis, M (2012) 'Study on the phenolic constituents of the flowers and leaves of Trifolium repens L', Natural Product Research, 26(21), pp. 2050-2054. doi:10.1080/14786419.2011.637217 Preclinical
https://doi.org/10.1080/14786419.2011.637217 - Ahmad, S. and Zeb, A (2019) 'Effects of phenolic compounds from aqueous extract of Trifolium repens against acetaminophen-induced hepatotoxicity in mice', Journal of Food Biochemistry, 43(9), pp. e12963. doi:10.1111/jfbc.12963 Preclinical
https://doi.org/10.1111/jfbc.12963 - Borczak, B. and Szewczyk, A. and Domagała, D. and Kapusta-Duch, J. and Leszczyńska, T. and Kotuła, M. and Grulova, D (2024) 'Potential Antidiabetic, Antioxidative and Antiproliferative Properties of Functional Wheat Flour Muffins Enriched with White Clover Flowers (Trifolium repens L.)', Int J Mol Sci, 25(18). doi:10.3390/ijms25189909 Preclinical
https://doi.org/10.3390/ijms25189909 - Rawat, P. and Kumar, B. and Misra, A. and Singh, S.P. and Singh, S.P. and Srivastava, S (2025) 'Effect of hydrolysed Trifolium repens L. extract on menopause-induced obesity and depressive symptoms: an in vitro and in vivo approach', Nat Prod Res, pp. 1-8. doi:10.1080/14786419.2025.2560636 Preclinical
https://doi.org/10.1080/14786419.2025.2560636 - Parić, A. and Mesic, A. and Mahmutović-Dizdarević, I. and Jerković-Mujkić, A. and Žujo, B. and Bašić, N. and Pustahija, F (2024) 'Bioactive potential of Trifolium repens L. essential oil', J Environ Sci Health B, 59(9), pp. 584-594. doi:10.1080/03601234.2024.2396730 Preclinical
https://doi.org/10.1080/03601234.2024.2396730 - Renda, G. and Yalçın, F.N. and Nemutlu, E. and Akkol, E.K. and Süntar, I. and Keleş, H. and Ina, H. and Çalış, I. and Ersöz, T (2013) 'Comparative assessment of dermal wound healing potentials of various Trifolium L. extracts and determination of their isoflavone contents as potential active ingredients', J Ethnopharmacol, 148(2), pp. 423-32. doi:10.1016/j.jep.2013.04.031 Preclinical
https://doi.org/10.1016/j.jep.2013.04.031 - Ahmed, I.A.M. and Matthäus, B. and Özcan, M.M. and Juhaimi, F.A. and Ghafoor, K. and Babiker, E.E. and Osman, M.A. and Alqah, H.A.S (2020) 'Determination of Bioactive Lipid and Antioxidant Activity of Onobrychis, Pimpinella, Trifolium, and Phleum spp. Seed and Oils', J Oleo Sci, 69(11), pp. 1367-1371. doi:10.5650/jos.ess20153 Preclinical
https://doi.org/10.5650/jos.ess20153 - Harlow, B.E. and Flythe, M.D. and Goodman, J.P. and Ji, H. and Aiken, G.E (2022) 'Isoflavone Containing Legumes Mitigate Ergot Alkaloid-Induced Vasoconstriction in Goats (Capra hircus)', Animals (Basel), 12(6). doi:10.3390/ani12060750 Preclinical
https://doi.org/10.3390/ani12060750 - Shang, H. and Li, R. and Wu, H. and Sun, Z (2019) 'Polysaccharides from Trifolium repens L. extracted by different methods and extraction condition optimization', Sci Rep, 9(1), pp. 6353. doi:10.1038/s41598-019-42877-5 Preclinical
https://doi.org/10.1038/s41598-019-42877-5 - Prati, S. and Baravelli, V. and Fabbri, D. and Schwarzinger, C. and Brandolini, V. and Maietti, A. and Tedeschi, P. and Benvenuti, S. and Macchia, M. and Marotti, I. and Bonetti, A. and Catizone, P. and Dinelli, G (2007) 'Composition and content of seed flavonoids in forage and grain legume crops', J Sep Sci, 30(4), pp. 491-501. doi:10.1002/jssc.200600383 Preclinical
https://doi.org/10.1002/jssc.200600383 - Woolsey, I.D. and Zeller, W.E. and Blomstrand, B.M. and Øines, Ø. and Enemark, H.L (2022) 'Effects of selected condensed tannins on Cryptosporidium parvum growth and proliferation in HCT-8 cell cultures', Exp Parasitol, 241, pp. 108353. doi:10.1016/j.exppara.2022.108353 Preclinical
https://doi.org/10.1016/j.exppara.2022.108353 - Hou, K. and Xue, Q. and Shi, L. and Liu, S. and Zhong, X. and Liu, Y. and Wang, C (2026) 'Identification of Trifolium repens as a New Source of Glycyrrhetinic Acid: Pathway Elucidation and Heterologous Reconstruction in Yeast', J Agric Food Chem, 74(19), pp. 15182-15194. doi:10.1021/acs.jafc.6c02001 Preclinical
https://doi.org/10.1021/acs.jafc.6c02001 - Tundis, R. and Marrelli, M. and Conforti, F. and Tenuta, M.C. and Bonesi, M. and Menichini, F. and Loizzo, M.R (2015) 'Trifolium pratense and T. repens (Leguminosae): Edible Flower Extracts as Functional Ingredients', Foods, 4(3), pp. 338-348. doi:10.3390/foods4030338 Preclinical
https://doi.org/10.3390/foods4030338 - Başar, Y. and Yıldız, İ. and HOSAFLIOĞLU, İ. and Azeroual, A. and Erenler, R (2026) 'The Phytochemical Content and DPPH Activity of Trifolium repens L. Methanol Extract, and In Silico Studies', Adıyaman üniversitesi fen bilimleri dergisi, 16(1), pp. 61-76. doi:10.37094/adyujsci.1813336 Preclinical
https://doi.org/10.37094/adyujsci.1813336 - Ayoubi, S.A. and Abdelwahab, I. and Ela, M.A. and Lakany, A.E. and Raafat, K (2026) 'Advanced Hybrid-Green Ultrasound–Infrared–Microwave Trifolium repens Essential oil Isolation with Multi-Target Ethnomedicine Bioactivity against Neuropathy, Inflammation and Multidrug-Resistant Infection', Journal of Food and Drug Analysis, 34(2). doi:10.38212/2224-6614.3595 Preclinical
https://doi.org/10.38212/2224-6614.3595 - Ahmad, S. and Zeb, A. and Ayaz, M. and Murkovic, M (2019) 'Characterization of phenolic compounds using UPLC–HRMS and HPLC–DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves', European Food Research and Technology, 246(3), pp. 485-496. doi:10.1007/s00217-019-03416-8 Preclinical
https://doi.org/10.1007/s00217-019-03416-8 - Petrović, M. and Stanković, M. and Anđelković, B. and Babić, S. and Zornić, V. and Vasiljević, S. and Stevanović, Z.D (2016) 'Quality Parameters and Antioxidant Activity of Three Clover Species in Relation to the Livestock Diet', Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 44(1), pp. 201-208. doi:10.15835/nbha44110144 Preclinical
https://doi.org/10.15835/nbha44110144 - Jakubczyk, K. and Łukomska, A. and Gutowska, I. and Kochman, J. and Janił, J. and Janda, K (2021) 'Edible Flowers Extracts as a Source of Bioactive Compounds with Antioxidant Properties—In Vitro Studies', Applied Sciences, 11(5), pp. 2120-2120. doi:10.3390/app11052120 Preclinical
https://doi.org/10.3390/app11052120 - Ngangom, L. and Venugopal, D. and Pandey, N. and Kumar, N (2022) 'In-silico screening and identification of potential bioactive compounds of Trifolium repens against pathogenic bacterial target proteins', Materials Today Proceedings, 73, pp. 142-150. doi:10.1016/j.matpr.2022.09.501 Preclinical
https://doi.org/10.1016/j.matpr.2022.09.501 - Amer, B. and Juul, L. and Møller, A.H. and Møller, H.S. and Dalsgaard, T.K (2020) 'Improved solubility of proteins from white and red clover – inhibition of redox enzymes', International Journal of Food Science & Technology, 56(1), pp. 302-311. doi:10.1111/ijfs.14632 Preclinical
https://doi.org/10.1111/ijfs.14632 - Pap, N. and Granato, D. and Järvenpää, E. and Tienaho, J. and Marnila, P. and Hellström, J. and Pihlava, J. and Franco, M. and Stefański, T. and Rinne, M (2024) 'Biorefining of legume and grass biomasses: Technological properties and bioactivities of the green juice', Future Foods, 9, pp. 100331-100331. doi:10.1016/j.fufo.2024.100331 Preclinical
https://doi.org/10.1016/j.fufo.2024.100331 - Ahn, C. and Lee, J. and Park, M.J. and Kim, J. and Yang, J. and Yoo, Y. and Jeung, E (2020) 'Cytostatic effects of plant essential oils on human skin and lung cells', Experimental and Therapeutic Medicine, 19(3), pp. 2008-2018. doi:10.3892/etm.2020.8460 Preclinical
https://doi.org/10.3892/etm.2020.8460 - Bhattacharya, S. et al (2013) 'Review of the botanical, phytochemical, pharmacological and toxicological properties of white clover (Trifolium repens L.)', 7(7), pp. 583--588. Traditional / reference
https://scholar.google.com/scholar?q=Review%20of%20the%20botanical%2C%20phytochemical%2C%20pharmacological%20and%20toxicological%20properties%20of%20white%20clover%20%28Trifolium%20repens%20L.%29 - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Klaiber, I. et al (2002) 'Health benefits of isoflavones from clover species', 16(1), pp. 1--8. Traditional / reference
https://scholar.google.com/scholar?q=Health%20benefits%20of%20isoflavones%20from%20clover%20species - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.